Long-Term immunopersistence and safety of the Escherichia coli-produced HPV-16/18 bivalent vaccine in Chinese adolescent girls

• Main Authors: Xingmei Yao (Author), Wengang He (Author), Xianghong Wu (Author), Jianxiang Gu (Author), Jing Zhang (Author), Bizhen Lin (Author), Zhaofeng Bi (Author), Yingying Su (Author), Shoujie Huang (Author), Yuemei Hu (Author), Ting Wu (Author), Jun Zhang (Author), Ningshao Xia (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The study assessed long-term immunopersistence and safety of the Escherichia coli (E. coli)-produced HPV-16/18 bivalent vaccine. In total, 979 participants in the initial immunogenicity noninferiority study, including girls aged 9-14 years who were randomized in a 1:1 ratio to receive 2 doses at mon...